Outcomes of Goniotomy With or Without Secondary Intraocular Lens Implantation in Pediatric Glaucoma Following Cataract Surgery: A Prospective Pilot Study

医学 四分位间距 眼压 青光眼 前瞻性队列研究 眼科 白内障手术 继发性青光眼 人工晶状体 外科
作者
Yu Zhang,Wan Chen,Tse‐Chun Lin,Xiulan Zhang,Dennis S.C. Lam,Weirong Chen
出处
期刊:Asia-Pacific journal of ophthalmology 卷期号:12 (5): 444-450 被引量:2
标识
DOI:10.1097/apo.0000000000000637
摘要

Purpose: To report the outcomes of a 120-degree goniotomy (GT) with or without secondary intraocular lens (IOL) implantation in glaucoma following cataract surgery (GFCS). Design: Prospective, observational study. Methods: Pediatric patients with GFCS who underwent standalone 120-degree GT or 120-degree GT combined with secondary IOL implantation (GT+IOL) from March 2022 to August 2022 at the Zhongshan Ophthalmic Center were recruited. Primary outcomes were intraocular pressure (IOP) and the number of ocular hypotensive medications. A secondary outcome was the surgical success rate. Success was defined as a postoperative IOP within the range of 5–21 mm Hg. Complete and qualified successes were defined, as the above, without and with ocular hypotensive medications, respectively. Results: Thirty-two eyes of 22 patients were included. The mean age at the time of GT was 68.5 ± 29.3 months. The mean follow-up duration was 12.2 ± 2.3 months (9–15 mo). Mean IOP decreased from 30.9 ± 4.8 mm Hg on 2 (interquartile range = 1) medications at baseline to 15.8 ± 3.6 mm Hg on 0 (interquartile range = 1.5) medication at the latest visit in all eyes. The overall complete and qualified success rates were 68.8% and 90.6%, respectively. There were no significant differences in IOP, number of medications, and complete and qualified success rates between the standalone GT and GT+IOL groups at the latest follow-up at 9 months postoperatively. Conclusions: To reduce the need for additional surgery, 120-degree GT was a safe and effective surgical treatment for GFCS in children, which could be combined with secondary IOL implantation in aphakic eyes with GFCS.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
完美世界应助幸福胡萝卜采纳,获得10
1秒前
通~发布了新的文献求助10
1秒前
2秒前
科目三应助Arnold采纳,获得10
2秒前
润润轩轩发布了新的文献求助10
3秒前
宗笑晴发布了新的文献求助10
3秒前
lucky完成签到,获得积分10
3秒前
糖糖发布了新的文献求助10
4秒前
4秒前
跳跃尔容完成签到,获得积分10
5秒前
wyblobin完成签到,获得积分10
5秒前
5秒前
6秒前
沉默沛岚完成签到,获得积分10
6秒前
丰知然应助宇文宛菡采纳,获得10
6秒前
所所应助tu采纳,获得30
7秒前
mechefy完成签到,获得积分10
7秒前
鲤鱼萧完成签到,获得积分10
8秒前
宗笑晴完成签到,获得积分10
8秒前
9秒前
小蘑菇应助头发乱了采纳,获得10
9秒前
代萌萌发布了新的文献求助10
10秒前
jucy发布了新的文献求助50
10秒前
10秒前
Lz完成签到,获得积分10
10秒前
Hello应助葛辉辉采纳,获得10
10秒前
秦嘉旎完成签到,获得积分10
11秒前
华仔应助通~采纳,获得10
11秒前
万能图书馆应助半颗橙子采纳,获得10
11秒前
樱铃完成签到,获得积分10
12秒前
12秒前
上官若男应助俭朴的明轩采纳,获得10
12秒前
1199发布了新的文献求助10
13秒前
英姑应助包容的过客采纳,获得10
14秒前
标致的战斗机完成签到,获得积分10
14秒前
科研人发布了新的文献求助10
15秒前
hl完成签到,获得积分10
15秒前
15秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527742
求助须知:如何正确求助?哪些是违规求助? 3107867
关于积分的说明 9286956
捐赠科研通 2805612
什么是DOI,文献DOI怎么找? 1540026
邀请新用户注册赠送积分活动 716884
科研通“疑难数据库(出版商)”最低求助积分说明 709762